Real-world outpatient parenteral antimicrobial therapy before national reimbursement: a retrospective cohort study from a Taiwanese cancer hospital
Antimicrobial Stewardship & Healthcare Epidemiology · 2026 · 6 (1)
DOI: 10.1017/ash.2026.10938 ↗Abstract
Abstract Before Taiwan’s national outpatient parenteral antimicrobial therapy (OPAT) reimbursement, we retrospectively evaluated 241 OPAT episodes among 173 patients at a cancer hospital. Median parenteral therapy duration was 7 days, with 73.0% clinical improvement and 24.9% unplanned admission. Modeled costs estimated savings of approximately US$137 per OPAT case when treatment days replaced hospitalization.
EUVIMED